Sanofi SA (NAS:SNY)
$ 48.29 -0.1 (-0.21%) Market Cap: 121.07 Bil Enterprise Value: 139.04 Bil PE Ratio: 26.55 PB Ratio: 1.57 GF Score: 84/100

Q3 2024 Sanofi SA Earnings Call Transcript

Oct 25, 2024 / 12:00PM GMT
Release Date Price: $54.34 (+4.40%)
Thomas Kudsk Larsen
Sanofi SA - Head of Investor Relations

Hello everyone, this is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q3 2024 conference call for investor and analysts. As usual, you can find the slides on sanofi.com. Please turn to slide number 3. Here we have the usual forward-looking statement.

We would like to remind you that information presented in this call contains forward-looking statements, which are subject to substantial risks and uncertainties that may cause actual results to differ materially. We encourage you to read the disclaimer in our slide presentation. In addition, we refer you to our Form 20-F on file with the USA SEC on d'Enregistrement document for a description of these risk factors.

As usual, we'll be making comments on our performance using constant exchange rates and other non-IFRS measures. Numbers used are in million euro and for Q3, 2024 unless stated otherwise. Please turn to slide number 4.

First, we have a presentation, then we'll take your questions. As last time we kept the presentation on the shorter side to allow

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot